This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishii, Y.
Right arrow Articles by Yamaguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishii, Y.
Right arrow Articles by Yamaguchi, K.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2005, p. 1072-1075, Vol. 43, No. 3
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.3.1072-1075.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Extended-Spectrum ß-Lactamase-Producing Shiga Toxin Gene (stx1)-Positive Escherichia coli O26:H11: a New Concern

Yoshikazu Ishii,1* Soichiro Kimura,1 Jimena Alba,1 Katsuaki Shiroto,1 Masanobu Otsuka,2 Naotaka Hashizume,2 Kazumichi Tamura,3 and Keizo Yamaguchi1

Department of Microbiology, Toho University School of Medicine,1 Department of Clinical Laboratory, Toho University Ohashi Hospital,2 Department of Bacteriology, National Institute of Infectious Diseases, Tokyo, Japan3

Received 4 August 2004/ Returned for modification 24 September 2004/ Accepted 3 October 2004

Escherichia coli strain TUM2139 was isolated from a stool sample from a 9-year-old girl on 16 June 2004. This strain was categorized as Shiga toxin-producing Escherichia coli (STEC) because the Shiga-like toxin gene stx1 was detected by immunochromatography and PCR assay. The strain was highly resistant to cefotaxime (256 µg/ml) and was also resistant to cefepime, cefpodoxime, ceftriaxone, and aztreonam. In the presence of 4 µg of clavulanic acid per ml, the MIC of cefotaxime decreased to ≤0.12 µg/ml, indicating that this strain was an extended-spectrum ß-lactamase (ESBL) producer. Cefotaxime resistance was transferred to E. coli C600 by conjugation at a frequency of 3.0 x 10–6. A PCR assay was performed with primer sets specific for TEM-type and SHV-type ESBLs and for the CTX-M-2 (Toho-1), CTX-M-3, and CTX-M-9 groups of ESBLs. A specific signal was observed with the primer set specific for the CTX-M-9 group of ß-lactamases. This ß-lactamase was confirmed to be the ESBL CTX-M-18 by DNA sequencing. This is the first report of an ESBL-producing STEC isolate.

* Corresponding author. Mailing address: Department of Microbiology, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 1438540 Tokyo, Japan. Phone: 81-3-3762-4151. Fax: 81-3-5493-5415. E-mail: yoishii{at}med.toho-u.ac.jp.

Journal of Clinical Microbiology, March 2005, p. 1072-1075, Vol. 43, No. 3
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.3.1072-1075.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»